RESUMEN

Bovine trypsin (EC 3.4.21.4) is an enzyme that is widely used for commercial purposes to digest or process other proteins, including some therapeutic proteins. The biopharmaceutical industry is trying to eliminate animal-derived proteins from manufacturing processes due to the possible contamination of these products by human pathogens. Recombinant trypsin has been produced in a number of systems, including cell culture, bacteria and yeast. To date, these expression systems have not produced trypsin on a scale sufficient to fulfill the need of biopharmaceutical manufacturers where kilogram quantities are often required. The present paper describes commercial-level production of trypsin in transgenic maize (Zea mays) and its physical and functional characterization. This protease, the first enzyme to be produced on a large-scale using transgenic plant technology, is functionally equivalent to native bovine pancreatic trypsin. The availability of this reagent should allow for the replacement of animal-derived trypsin in the processing of pharmaceutical proteins.

Asunto(s)

Plantas Modificadas Genéticamente/enzimología , Tripsina/genética , Zea mays/genética , Animales , Bovinos , Clonación Molecular , Activación Enzimática , Harina , Glicosilación , Humanos , Cinética , Plantas Modificadas Genéticamente/química , Proteínas Recombinantes/biosíntesis , Proteínas Recombinantes/química , Semillas/química , Semillas/enzimología , Tripsina/biosíntesis , Tripsina/metabolismo , Tripsinógeno/metabolismo , Zea mays/química , Zea mays/enzimología